Akari Therapeutics, Plc
AKTX · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 18, 2026 | — | — | — | -1.39 | — |
| 2026 Q1 | May 19, 2026 | — | — | -1.33 | -1.33 | +49.85% |
| 2025 Q4 | March 30, 2026 | — | — | -32.00 | — | — |
| 2025 Q3 | November 13, 2025 | — | — | -0.10 | -0.04 | -6.01% |
| 2025 Q2 | August 13, 2025 | — | — | -0.06 | -0.09 | -0.86% |
| 2025 Q1 | May 15, 2025 | — | — | -0.14 | — | -3.79% |
| 2024 Q4 | April 16, 2025 | — | — | -0.17 | -1.00 | — |
| 2024 Q2 | August 19, 2024 | — | — | -3.20 | -1.00 | — |
| 2024 Q1 | May 16, 2024 | — | — | -3.20 | -1.00 | — |
| 2023 Q4 | April 1, 2024 | — | — | -2.40 | — | — |
| 2023 Q2 | September 29, 2023 | — | — | -2.40 | -0.60 | +6.30% |
| 2022 Q4 | May 1, 2023 | — | — | — | — | — |
| 2022 Q2 | September 27, 2022 | — | — | -80.00 | — | -0.28% |
| 2022 Q1 | July 20, 2022 | — | — | — | — | — |
| 2021 Q4 | May 16, 2022 | — | — | -96.00 | — | — |
| 2021 Q3 | December 3, 2021 | — | — | -0.60 | — | — |